+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United Kingdom Hip Reconstruction Market Outlook to 2025

  • PDF Icon

    Report

  • 56 Pages
  • June 2018
  • Region: United Kingdom
  • GlobalData
  • ID: 4580312
United Kingdom Hip Reconstruction Market Outlook to 2025

Summary

This new report, United Kingdom Hip Reconstruction Market Outlook to 2025, provides key market data on the United Kingdom Hip Reconstruction market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories - Hip Resurfacing, Partial Hip Replacement, Primary Hip Replacement and Revision Hip Replacement.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Hip Reconstruction market categories - Hip Resurfacing, Partial Hip Replacement, Primary Hip Replacement and Revision Hip Replacement.

  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.

  • 2017 company share and distribution share data for Hip Reconstruction market.

  • Global corporate-level profiles of key companies operating within the United Kingdom Hip Reconstruction market.

  • Key players covered include Stryker Corp, Zimmer Biomet Holdings Inc, DePuy Synthes Inc and Others.


Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.

  • Develop market-entry and market expansion strategies.

  • Design competition strategies by identifying who-stands-where in the market.

  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Hip Reconstruction Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Hip Reconstruction Market, United Kingdom
3.1 Hip Reconstruction Market, United Kingdom, Revenue ($m), 2015-2025
3.1.1 Partial Hip Replacement Market, United Kingdom, Revenue ($m), by Segment, 2015-2025
3.1.2 Primary Hip Replacement Market, United Kingdom, Revenue ($m), by Segment, 2015-2025
3.2 Hip Reconstruction Market, United Kingdom, Volume (Units), 2015-2025
3.2.1 Partial Hip Replacement Market, United Kingdom, Volume (Units), by Segment, 2015-2025
3.2.2 Primary Hip Replacement Market, United Kingdom, Volume (Units), by Segment, 2015-2025
3.3 Hip Reconstruction Market, United Kingdom, Average Price ($), 2015-2025
3.4 Hip Reconstruction Market, United Kingdom, Distribution Share by Revenue ($m), 2017
3.5 Hip Reconstruction Market, United Kingdom, Company Share by Revenue ($m), 2017
4 Overview of Key Companies in United Kingdom, Hip Reconstruction Market
4.1 Zimmer Biomet Holdings Inc
4.1.1 Company Overview
4.2 DePuy Synthes Inc
4.2.1 Company Overview
4.3 Stryker Corp
4.3.1 Company Overview
4.4 Corin Group PLC
4.4.1 Company Overview
4.5 Smith & Nephew Plc
4.5.1 Company Overview
5 Hip Reconstruction Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 AK Medical to Acquire JRI Orthopaedics from Orthopaedic Research for USD23.6 Million
6.2 Private Equity
6.2.1 Apposite Capital Acquries OrthoD from Riverside
6.2.2 Elliott Management May Acquire Stake in Smith & Nephew
7 Recent Developments
7.1 Corporate Communications
7.1.1 May 08, 2018: Smith & Nephew: Change of Directorate
7.1.2 Apr 05, 2018: ADAPT Pharma Welcomes Surgeon General Naloxone Advisory
7.1.3 Apr 04, 2018: Namal Nawana appointed Chief Executive Officer of Smith & Nephew
7.1.4 Mar 20, 2018: Governor Abbott Announces Smith & Nephew Adding New Jobs In Fort Worth
7.1.5 Mar 01, 2018: Smith & Nephew: Change in Directorate
7.1.6 Jan 31, 2018: Smith & Nephew Appoints Roland Diggelmann As Non-Executive Director
7.1.7 Jan 31, 2018: Appointment of Roland Diggelmann as Non-Executive Director
7.1.8 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
7.1.9 Oct 09, 2017: Smith & Nephew: Notice of Chief Executive Officer’s intention to retire by end of 2018
7.1.10 Oct 09, 2017: Notice of Chief Executive Officer’s intention to retire by end of 2018
7.1.11 Oct 02, 2017: Smith & Nephew Announces Directorate Change
7.1.12 Sep 18, 2017: Smith & Nephew Announces Change in Board of Directors
7.1.13 Sep 12, 2017: Smith & Nephew: Appointment of Marc Owen as Non-Executive Director
7.1.14 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee
7.2 Financial Announcements
7.2.1 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report
7.2.2 Feb 08, 2018: Smith & Nephew Fourth Quarter Trading and Full Year 2017 Results
7.2.3 Jan 08, 2018: BerGenBio to present at Biotech Showcase 2018
7.2.4 Nov 06, 2017: KemPharm Receives USAN Approval for “Asalhydromorphone” as Nonproprietary Name for Novel Prodrug Candidate, KP511
7.2.5 Nov 03, 2017: Smith & Nephew Third Quarter 2017 Trading Report
7.2.6 Oct 06, 2017: Bruker Introduces Fungiplex Candida Assay into European Clinical Microbiology Markets
7.2.7 Oct 06, 2017: Integra LifeSciences launches Revize Collagen Matrix for Plastic and Reconstructive Surgery
7.2.8 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results
7.3 Legal And Regulatory
7.3.1 Oct 09, 2017: USCOM cost effective replacement for ICU Ultrasound
7.4 Strategy And Business Planning
7.4.1 Jun 13, 2017: JRI Orthopaedics launches international centre of orthopaedic excellence
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact Us
8.4 Disclaimer
List of Tables
Table 1: Hip Reconstruction Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 2: Hip Reconstruction Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 3: Partial Hip Replacement Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 4: Partial Hip Replacement Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 5: Primary Hip Replacement Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 6: Primary Hip Replacement Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 7: Hip Reconstruction Market, United Kingdom, Volume (Units), 2015-2020
Table 8: Hip Reconstruction Market, United Kingdom, Volume (Units), 2021-2025
Table 9: Partial Hip Replacement Market, United Kingdom, Volume (Units), 2015-2020
Table 10: Partial Hip Replacement Market, United Kingdom, Volume (Units), 2021-2025
Table 11: Primary Hip Replacement Market, United Kingdom, Volume (Units), 2015-2020
Table 12: Primary Hip Replacement Market, United Kingdom, Volume (Units), 2021-2025
Table 13: Hip Reconstruction Market, United Kingdom, Average Price ($), 2015-2020
Table 14: Hip Reconstruction Market, United Kingdom, Average Price ($), 2021-2025
Table 15: Hip Reconstruction Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2017
Table 16: Hip Reconstruction Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2017
Table 17: Hip Reconstruction Market Pipeline Products
Table 18: AK Medical to Acquire JRI Orthopaedics from Orthopaedic Research for USD23.6 Million
Table 19: Apposite Capital Acquries OrthoD from Riverside
Table 20: Elliott Management May Acquire Stake in Smith & Nephew
Table 21: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country
List of Figures
Figure 1: Hip Reconstruction Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 2: Partial Hip Replacement Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 3: Primary Hip Replacement Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 4: Hip Reconstruction Market, United Kingdom, Volume (Units), 2015-2025
Figure 5: Partial Hip Replacement Market, United Kingdom, Volume (Units), 2015-2025
Figure 6: Primary Hip Replacement Market, United Kingdom, Volume (Units), 2015-2025
Figure 7: Hip Reconstruction Market, United Kingdom, Company Share (%) 2017

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Zimmer Biomet Holdings Inc

  • DePuy Synthes Inc

  • Stryker Corp

  • Corin Group PLC

  • Smith & Nephew Plc